Compositions and methods for organ-protective expression and modulation of coding ribonucleic acids | Patent Number 11931409

US 11931409 B2
Application Number18108248
Publication NumberUS 20230241206 A1
Pendency1 year, 1 month, 8 days
Filled DateFeb 10, 2023
Priority DateFeb 21, 2020
Publication DateAug 3, 2023
Expiration DateFeb 20, 2040
Inventor/ApplicantsValerie Duval
Romain Micol
ExaminesZOU, NIANXIANG
Art Unit1648
Technology Center1600
Assignments
Combined Therapeutics Inc.
Current
Combined Therapeutics Inc.
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.